-
2
-
-
0022381173
-
-
Odonohue T.L., Chronwall B.M., Pruss R.M., Mezey E., Kiss J.Z., Eiden L.E., Massari V.J., Tessel R.E., Pickel V.M., Dimaggio D.A., Hotchkiss A.J., Crowley W.R., and ZukowskaGrojec Z. Peptides 6 (1985) 755
-
(1985)
Peptides
, vol.6
, pp. 755
-
-
Odonohue, T.L.1
Chronwall, B.M.2
Pruss, R.M.3
Mezey, E.4
Kiss, J.Z.5
Eiden, L.E.6
Massari, V.J.7
Tessel, R.E.8
Pickel, V.M.9
Dimaggio, D.A.10
Hotchkiss, A.J.11
Crowley, W.R.12
ZukowskaGrojec, Z.13
-
5
-
-
0026637310
-
-
Stanley B.G., Magdalin W., Seirafi A., Nguyen M.M., and Leibowitz S.F. Peptides 13 (1992) 581
-
(1992)
Peptides
, vol.13
, pp. 581
-
-
Stanley, B.G.1
Magdalin, W.2
Seirafi, A.3
Nguyen, M.M.4
Leibowitz, S.F.5
-
7
-
-
0026663603
-
-
Kalra S.P., Fuentes M., Fournier A., Parker S.L., and Crowley W.R. Endocrinology 130 (1992) 3323
-
(1992)
Endocrinology
, vol.130
, pp. 3323
-
-
Kalra, S.P.1
Fuentes, M.2
Fournier, A.3
Parker, S.L.4
Crowley, W.R.5
-
10
-
-
33749605966
-
-
Eva C., Serra M., Mele P., Panzica G., and Oberto A. Front. Neuroendocrinol. 27 (2006) 308
-
(2006)
Front. Neuroendocrinol.
, vol.27
, pp. 308
-
-
Eva, C.1
Serra, M.2
Mele, P.3
Panzica, G.4
Oberto, A.5
-
11
-
-
33845889758
-
-
For recent reviews:
-
For recent reviews:. Ishihara A., Moriya M., MacNeil D.J., Fukami T., and Kanatani A. Exp. Opin. Therap. Patents 16 (2006) 1701
-
(2006)
Exp. Opin. Therap. Patents
, vol.16
, pp. 1701
-
-
Ishihara, A.1
Moriya, M.2
MacNeil, D.J.3
Fukami, T.4
Kanatani, A.5
-
15
-
-
2342436512
-
-
Elsinga P.H., Hendrikse N.H., Bart J., Vaalburg W., and van Waarde A. Curr. Pharm. Des. 10 (2004) 1493
-
(2004)
Curr. Pharm. Des.
, vol.10
, pp. 1493
-
-
Elsinga, P.H.1
Hendrikse, N.H.2
Bart, J.3
Vaalburg, W.4
van Waarde, A.5
-
16
-
-
68349145828
-
-
For tritium-labeled NPY Y1 antagonists for in vitro studies of this receptor, see:
-
For tritium-labeled NPY Y1 antagonists for in vitro studies of this receptor, see:. Keller M., Pop N., Hutzler C., Beck-Sickinger A.G., Bernhardt G., and Buschauer A. J. Med. Chem. 51 (2008) 8166
-
(2008)
J. Med. Chem.
, vol.51
, pp. 8166
-
-
Keller, M.1
Pop, N.2
Hutzler, C.3
Beck-Sickinger, A.G.4
Bernhardt, G.5
Buschauer, A.6
-
17
-
-
0029051438
-
-
Entzeroth M., Braunger H., Eberlein W., Engel W., Rudolf K., Wienen W., Wieland H.A., Willim K.D., and Doods H.N. Eur. J. Pharmacol. 278 (1995) 239
-
(1995)
Eur. J. Pharmacol.
, vol.278
, pp. 239
-
-
Entzeroth, M.1
Braunger, H.2
Eberlein, W.3
Engel, W.4
Rudolf, K.5
Wienen, W.6
Wieland, H.A.7
Willim, K.D.8
Doods, H.N.9
-
18
-
-
37549071920
-
-
For fluorescent NPY Y1 antagonist, see:
-
For fluorescent NPY Y1 antagonist, see:. Schneider E., Keller M., Brennauer A., Hoefelschweiger B.K., Gross D., Wolfbeis O.S., Bernhardt G., and Buschauer A. ChemBioChem 16 (2007) 1981
-
(2007)
ChemBioChem
, vol.16
, pp. 1981
-
-
Schneider, E.1
Keller, M.2
Brennauer, A.3
Hoefelschweiger, B.K.4
Gross, D.5
Wolfbeis, O.S.6
Bernhardt, G.7
Buschauer, A.8
-
19
-
-
67649987378
-
-
Kameda M., Kobayashi K., Ito H., Miyazoe H., Tsujino T., Nakama C., Kawamoto H., Ando M., Ito S., Suzuki T., Kanno T., Tanaka T., Tahara Y., Tani T., Tanaka S., Tokita S., and Sato N. Bioorg. Med. Chem. Lett. 19 (2009) 4325
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 4325
-
-
Kameda, M.1
Kobayashi, K.2
Ito, H.3
Miyazoe, H.4
Tsujino, T.5
Nakama, C.6
Kawamoto, H.7
Ando, M.8
Ito, S.9
Suzuki, T.10
Kanno, T.11
Tanaka, T.12
Tahara, Y.13
Tani, T.14
Tanaka, S.15
Tokita, S.16
Sato, N.17
-
20
-
-
0035125558
-
-
see also:
-
see also:. Kanatani A., Hata M., Mashiko S., Ishihara A., Okamoto O., Haga Y., Ohe T., Kanno T., Murai N., Ishii Y., Fukuroda T., Fukami T., and Ihara M. Mol. Pharmacol. 59 (2001) 501
-
(2001)
Mol. Pharmacol.
, vol.59
, pp. 501
-
-
Kanatani, A.1
Hata, M.2
Mashiko, S.3
Ishihara, A.4
Okamoto, O.5
Haga, Y.6
Ohe, T.7
Kanno, T.8
Murai, N.9
Ishii, Y.10
Fukuroda, T.11
Fukami, T.12
Ihara, M.13
-
21
-
-
68349150179
-
-
PCT Int. Appl. WO 9734873
-
Fukami, T.; Mase, T.; Tsuchiya, Y.; Kanatani, A.; Fukuroda, T. PCT Int. Appl. WO 9734873.
-
-
-
Fukami, T.1
Mase, T.2
Tsuchiya, Y.3
Kanatani, A.4
Fukuroda, T.5
-
22
-
-
0032819808
-
-
18F]-labeling of the 2-position of pyridine rings, see:
-
18F]-labeling of the 2-position of pyridine rings, see:. Dolci L., Dolle F., Jubeau S., Vaufrey F., and Crouzel C. J. Label. Compd. Radiopharm. 42 (1999) 975
-
(1999)
J. Label. Compd. Radiopharm.
, vol.42
, pp. 975
-
-
Dolci, L.1
Dolle, F.2
Jubeau, S.3
Vaufrey, F.4
Crouzel, C.5
-
23
-
-
68349152057
-
-
For the preparation of 4,5,6,7-tetrahydrobenzoxazole-2-thiol for compound 2k, see: Bobosik, V.; Piklerova, A.; Martvon, A. Collect. Czech. Chem. Commun. 1983, 48, 3421. 4,5-Dimethyloxazole-2-thiol for 2a-i and 5-ethyl-4-methyloxazole-2-thiol for 2j were prepared in a similar manner. 4,5-Dimethylthiazole-2-thiol for 2l is commercially available (Wako Pure Chemical Industries, Ltd).
-
For the preparation of 4,5,6,7-tetrahydrobenzoxazole-2-thiol for compound 2k, see: Bobosik, V.; Piklerova, A.; Martvon, A. Collect. Czech. Chem. Commun. 1983, 48, 3421. 4,5-Dimethyloxazole-2-thiol for 2a-i and 5-ethyl-4-methyloxazole-2-thiol for 2j were prepared in a similar manner. 4,5-Dimethylthiazole-2-thiol for 2l is commercially available (Wako Pure Chemical Industries, Ltd).
-
-
-
-
24
-
-
68349140913
-
-
note
-
125I]PYY (25 pM) at 25 °C for 120 min. Following three washes, the membrane-bound radioactivity was measured using a TopCount™ microplate scintillation counter (Packard, Meriden, CT). Non-specific binding was determined in the presence of an excess amount of cold porcine PYY (1 μM).
-
-
-
-
25
-
-
35848955911
-
-
Dohta Y., Yamashita T., Horiike S., Nakamura T., and Fukami T. Anal. Chem. 79 (2007) 8312
-
(2007)
Anal. Chem.
, vol.79
, pp. 8312
-
-
Dohta, Y.1
Yamashita, T.2
Horiike, S.3
Nakamura, T.4
Fukami, T.5
-
26
-
-
41349111685
-
-
11C]-labeling of the 2-position of pyridine rings, see:
-
11C]-labeling of the 2-position of pyridine rings, see:. Bourdier T., Huiban M., Huet A., Sobrio F., Fouquet E., Perrio C., and Barre L. Synthesis 6 (2008) 978
-
(2008)
Synthesis
, vol.6
, pp. 978
-
-
Bourdier, T.1
Huiban, M.2
Huet, A.3
Sobrio, F.4
Fouquet, E.5
Perrio, C.6
Barre, L.7
-
27
-
-
23444449505
-
-
Huang Y., Narendran R., Bischoff F., Guo N., Zhu Z., Bae S., Lesage A.S., and Laruelle M. J. Med. Chem. 48 (2005) 5096
-
(2005)
J. Med. Chem.
, vol.48
, pp. 5096
-
-
Huang, Y.1
Narendran, R.2
Bischoff, F.3
Guo, N.4
Zhu, Z.5
Bae, S.6
Lesage, A.S.7
Laruelle, M.8
-
28
-
-
0034720445
-
-
Kanatani A., Ishihara A., Iwaasa H., Nakamura K., Okamoto O., Hidaka M., Ito J., Fukuroda T., MacNeil D.J., Van der Ploeg L.H.T., Ishii Y., Okabe T., Fukami T., and Ihara M. Biochem. Biophys. Res. Commun. 272 (2000) 169
-
(2000)
Biochem. Biophys. Res. Commun.
, vol.272
, pp. 169
-
-
Kanatani, A.1
Ishihara, A.2
Iwaasa, H.3
Nakamura, K.4
Okamoto, O.5
Hidaka, M.6
Ito, J.7
Fukuroda, T.8
MacNeil, D.J.9
Van der Ploeg, L.H.T.10
Ishii, Y.11
Okabe, T.12
Fukami, T.13
Ihara, M.14
-
29
-
-
0035119989
-
-
For the experimental details for the determination of the transcellular transport ratio see:
-
For the experimental details for the determination of the transcellular transport ratio see:. Yamazaki M., Neway W.E., Ohe T., Chen I., Rowe J.F., Hochman J.H., Chiba M., and Lin J.H. J. Pharmacol. Exp. Ther. 296 (2001) 723
-
(2001)
J. Pharmacol. Exp. Ther.
, vol.296
, pp. 723
-
-
Yamazaki, M.1
Neway, W.E.2
Ohe, T.3
Chen, I.4
Rowe, J.F.5
Hochman, J.H.6
Chiba, M.7
Lin, J.H.8
|